US 7919484
Combination therapy
granted A61KA61K31/00A61K31/4439
Quick answer
US patent 7919484 (Combination therapy) held by Xenon Pharmaceuticals Inc. expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/00, A61K31/4439, A61K31/64, A61K38/28